Small Non-coding RNAs-based Bone Regulation and Targeting Therapeutic Strategies

Overview

Journal Mol Cell Endocrinol

Specialties Cell Biology
Endocrinology
Molecular Biology

Date 2016 Nov 27

PMID 27888003

Citations 13

Authors

Ying Yang

Sijie Fang

Affiliations

Soon will be listed here.

Abstract

Small non-coding RNAs, which are 20-25 nucleotide ribonucleic acids, have emerged as an important transformation in the biological evolution over almost three decades. microRNAs (miRNAs) and short interfering RNAs (siRNAs) are two significant categories of the small RNAs that exert important effects on bone endocrinology and skeletology. Therefore, clarifying the expression and function of these important molecules in bone endocrine physiology and pathology is of great significance for improving their potential therapeutic value for metabolism-associated bone diseases. In the present review, we highlight the recent advances made in understanding the function and molecular mechanism of these small non-coding RNAs in bone metabolism, especially their potentially therapeutic values in bone-related diseases.

Citing Articles

The circulatory levels and bone expression of MIR21, 34a, 155 and their target genes in a section of Egyptian Population.

El-Tahan R, Oriquat G, Sorour I, Salem S, Kamel M, Michel T Sci Rep. 2024; 14(1):27779.

PMID: 39537688 PMC: 11561067. DOI: 10.1038/s41598-024-77643-9.

Circ_ST6GAL1-mediated competing endogenous RNA network regulates TGF-β1-stimulated matrix Metalloproteinase-13 expression via Runx2 acetylation in osteoblasts.

Saranya I, Akshaya R, Gomathi K, Mohanapriya R, He Z, Partridge N Noncoding RNA Res. 2023; 9(1):153-164.

PMID: 38035043 PMC: 10686813. DOI: 10.1016/j.ncrna.2023.11.002.

Network regulatory mechanism of ncRNA on the Wnt signaling pathway in osteoporosis.

An F, Meng X, Yuan L, Niu Y, Deng J, Li Z Cell Div. 2023; 18(1):3.

PMID: 36879309 PMC: 9990358. DOI: 10.1186/s13008-023-00086-7.

Exploration of microRNA-106b-5p as a therapeutic target in intervertebral disc degeneration: a preclinical study.

Meng D, Chen W, Pan C, Yang K, Guan Y, Wang J Apoptosis. 2022; 28(1-2):199-209.

PMID: 36308623 DOI: 10.1007/s10495-022-01773-6.

Regulation of osteoclast-mediated bone resorption by microRNA.

Ji L, Li X, He S, Chen S Cell Mol Life Sci. 2022; 79(6):287.

PMID: 35536437 PMC: 11071904. DOI: 10.1007/s00018-022-04298-y.

References

Ramasubramanian A, Jeeawoody S, Yang F . Gene delivery of osteoinductive signals to a human fetal osteoblast cell line induces cell death in a dose-dependent manner. Drug Deliv Transl Res. 2015; 5(2):160-7. DOI: 10.1007/s13346-013-0163-x. View

Aravin A, Sachidanandam R, Girard A, Fejes-Toth K, Hannon G . Developmentally regulated piRNA clusters implicate MILI in transposon control. Science. 2007; 316(5825):744-7. DOI: 10.1126/science.1142612. View

Ma L, Teruya-Feldstein J, Weinberg R . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449(7163):682-8. DOI: 10.1038/nature06174. View

Wu P, Liang J, Yu F, Zhou Z, Tang J, Li K . miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1. Oncotarget. 2016; 7(27):42241-42251. PMC: 5173131. DOI: 10.18632/oncotarget.9948. View

Djuranovic S, Nahvi A, Green R . miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science. 2012; 336(6078):237-40. PMC: 3971879. DOI: 10.1126/science.1215691. View

Xu Y, Liu J, He M, Liu R, Belegu V, Dai P . Mechanisms of PDGF siRNA-mediated inhibition of bone cancer pain in the spinal cord. Sci Rep. 2016; 6:27512. PMC: 4901320. DOI: 10.1038/srep27512. View

Weilner S, Skalicky S, Salzer B, Keider V, Wagner M, Hildner F . Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation. Bone. 2015; 79:43-51. DOI: 10.1016/j.bone.2015.05.027. View

Heilmeier U, Hackl M, Skalicky S, Weilner S, Schroeder F, Vierlinger K . Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro. J Bone Miner Res. 2016; 31(12):2173-2192. DOI: 10.1002/jbmr.2897. View

Ao M, Williams K, Bhowmick N, Hayward S . Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res. 2006; 66(16):8007-16. PMC: 4067141. DOI: 10.1158/0008-5472.CAN-05-4451. View

10.

Cholas R, Padmanabhan S, Gervaso F, Udayan G, Monaco G, Sannino A . Scaffolds for bone regeneration made of hydroxyapatite microspheres in a collagen matrix. Mater Sci Eng C Mater Biol Appl. 2016; 63:499-505. DOI: 10.1016/j.msec.2016.03.022. View

11.

Qin L, Yao D, Zheng L, Liu W, Liu Z, Lei M . Phytomolecule icaritin incorporated PLGA/TCP scaffold for steroid-associated osteonecrosis: Proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits. Biomaterials. 2015; 59:125-43. PMC: 7111223. DOI: 10.1016/j.biomaterials.2015.04.038. View

12.

Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao D . miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol. 2015; 12(3):343-53. PMC: 4615895. DOI: 10.1080/15476286.2015.1017205. View

13.

Takaishi H, Kimura T, Dalal S, Okada Y, DArmiento J . Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol. 2008; 9(1):47-54. DOI: 10.2174/138920108783497659. View

14.

Carthew R, Sontheimer E . Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009; 136(4):642-55. PMC: 2675692. DOI: 10.1016/j.cell.2009.01.035. View

15.

Rodan G, Martin T . Therapeutic approaches to bone diseases. Science. 2000; 289(5484):1508-14. DOI: 10.1126/science.289.5484.1508. View

16.

Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L . Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994; 331(14):889-95. DOI: 10.1056/NEJM199410063311401. View

17.

Wang Y, Grainger D . RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Adv Drug Deliv Rev. 2011; 64(12):1341-57. PMC: 3293106. DOI: 10.1016/j.addr.2011.09.002. View

18.

Martin T, Sims N . Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005; 11(2):76-81. DOI: 10.1016/j.molmed.2004.12.004. View

19.

Rios C, Skoracki R, Mathur A . GNAS1 and PHD2 short-interfering RNA support bone regeneration in vitro and in an in vivo sheep model. Clin Orthop Relat Res. 2012; 470(9):2541-53. PMC: 3830105. DOI: 10.1007/s11999-012-2475-4. View

20.

Liao L, Yang X, Su X, Hu C, Zhu X, Yang N . Redundant miR-3077-5p and miR-705 mediate the shift of mesenchymal stem cell lineage commitment to adipocyte in osteoporosis bone marrow. Cell Death Dis. 2013; 4:e600. PMC: 3641352. DOI: 10.1038/cddis.2013.130. View